COG6 Gene Glycosylation Disorder Type 3 Genetic Test sale cost 4400 AED
ALG13 Gene Glycosylation Disorder Type 1S Genetic Test sale cost 4400 AED ALG13 Gene Glycosylation Disorder Type 1S Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
HAMP Gene Hemochromatosis Type 2B Genetic Test sale cost 4400 AED HAMP Gene Hemochromatosis Type 2B Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

COG6 Gene Glycosylation Disorder Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The COG6 Gene Glycosylation Disorder Type 3 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the COG6 gene, which are implicated in causing a rare genetic disorder known as Congenital Disorders of Glycosylation Type IIj (CDG-IIj). This condition affects the normal process of glycosylation, an essential biological mechanism where sugars are attached to proteins and lipids, impacting various bodily functions and leading to a spectrum of clinical manifestations. These can range from mild to severe and may include developmental delay, liver dysfunction, coagulation abnormalities, and neurological issues, among others.

The test, priced at 4400 AED, involves collecting a DNA sample, typically through a blood draw, which is then analyzed using advanced genetic sequencing technologies to detect any abnormalities or mutations in the COG6 gene. This precise genetic testing allows for an accurate diagnosis, enabling healthcare providers to tailor treatment and management plans to the specific needs of the patient. It also offers critical information for family planning and genetic counseling for families affected by this disorder.

Given the complexity of Congenital Disorders of Glycosylation and the significant impact they can have on individuals and families, the COG6 Gene Glycosylation Disorder Type 3 Genetic Test represents a crucial step forward in understanding and managing this rare condition. DNA Labs UAE, with its commitment to providing cutting-edge genetic testing services, ensures that patients and their families have access to the necessary resources for accurate diagnosis and informed healthcare decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

COG6 Gene Glycosylation Disorder Type 3 Genetic Test

Components

  • Test Name: COG6 Gene Glycosylation Disorder Type 3 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for COG6 Gene Glycosylation Disorder Type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation Disorder Type 3.

Test Details

COG6 gene glycosylation disorder type 3 NGS genetic test is a diagnostic test that uses Next-Generation Sequencing (NGS) technology to analyze the DNA sequence of the COG6 gene. This test is used to identify mutations or variations in the COG6 gene that are associated with glycosylation disorder type 3.

Glycosylation disorders are a group of genetic disorders characterized by abnormal glycosylation, which is the process of attaching sugar molecules to proteins or lipids. These disorders can affect various organs and systems in the body, leading to a wide range of symptoms and complications.

COG6 gene glycosylation disorder type 3 is caused by mutations in the COG6 gene, which encodes a protein involved in the transport of proteins and lipids within cells. Mutations in this gene disrupt the normal glycosylation process, leading to the symptoms and complications of the disorder.

NGS technology allows for the simultaneous sequencing of multiple genes, including the COG6 gene, in a more efficient and cost-effective manner compared to traditional sequencing methods. By analyzing the DNA sequence of the COG6 gene, this test can identify specific mutations or variations that are associated with glycosylation disorder type 3.

The results of the COG6 gene glycosylation disorder type 3 NGS genetic test can help confirm a diagnosis of the disorder and provide important information for genetic counseling and management of the condition. It can also be used for carrier testing in individuals with a family history of the disorder.

It’s important to note that this test is typically performed by healthcare professionals, such as geneticists or genetic counselors, who are specialized in genetic testing and interpretation. They will be able to provide appropriate guidance and counseling based on the test results.

Test Name COG6 Gene Glycosylation disorder type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for COG6 Gene Glycosylation disorder type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 3
Test Details

COG6 gene glycosylation disorder type 3 NGS genetic test is a diagnostic test that uses Next-Generation Sequencing (NGS) technology to analyze the DNA sequence of the COG6 gene. This test is used to identify mutations or variations in the COG6 gene that are associated with glycosylation disorder type 3.

Glycosylation disorders are a group of genetic disorders characterized by abnormal glycosylation, which is the process of attaching sugar molecules to proteins or lipids. These disorders can affect various organs and systems in the body, leading to a wide range of symptoms and complications.

COG6 gene glycosylation disorder type 3 is caused by mutations in the COG6 gene, which encodes a protein involved in the transport of proteins and lipids within cells. Mutations in this gene disrupt the normal glycosylation process, leading to the symptoms and complications of the disorder.

NGS technology allows for the simultaneous sequencing of multiple genes, including the COG6 gene, in a more efficient and cost-effective manner compared to traditional sequencing methods. By analyzing the DNA sequence of the COG6 gene, this test can identify specific mutations or variations that are associated with glycosylation disorder type 3.

The results of the COG6 gene glycosylation disorder type 3 NGS genetic test can help confirm a diagnosis of the disorder and provide important information for genetic counseling and management of the condition. It can also be used for carrier testing in individuals with a family history of the disorder.

It’s important to note that this test is typically performed by healthcare professionals, such as geneticists or genetic counselors, who are specialized in genetic testing and interpretation. They will be able to provide appropriate guidance and counseling based on the test results.

SKU: TEST-2400 Category:

Related products